Peak6 LLC Summit Therapeutics Inc. Transaction History

Peak6 LLC

  • $45.9 Billion
  • Q4 2024

A detailed history of Peak6 LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Peak6 LLC holds 20,000 shares of SMMT stock, worth $432,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$432,000
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$17.52 - $23.46 $294,861 - $394,831
16,830 New
16,830 $300,000

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.35B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email